• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Obstetrics

Laparoscopic hysterectomy equivalent to abdominal hysterectomy in disease-free and overall survival

byMichael MilliganandAdarsh Manjunath
March 31, 2017
in Obstetrics, Oncology, Surgery
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Among women with stage I endometrial cancer, total laparoscopic hysterectomy compared to total abdominal hysterectomy resulted in equivalent disease-free survival at 4.5 years.

2. No statistically significant differences were found in recurrence of endometrial cancer or overall survival between the groups.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Endometrial cancer is the most common gynecological cancer in developed countries and it is treated surgically by removing the uterus, both Fallopian tubes, and both ovaries. Laparoscopic hysterectomy has risen in popularity over open total abdominal hysterectomy due to its potential for less morbidity and pain, and its quicker recovery. However, it’s unknown if overall survival and outcomes are equivalent between the two procedures. This study randomized 760 women with stage I endometrial cancer between 2005 and 2010 at 20 different gynecological centers to total abdominal hysterectomy (TAH) or total laparoscopic hysterectomy (TLH). At 4.5 years of follow-up, the use of TAH compared with TLH resulted in equivalent disease-free survival of 81.3% in the TAH group and 81.6% in the TLH group. There was no statistically significant difference in recurrence of endometrial cancer or in overall survival.

Overall, this study suggests that for women with early-stage endometrial cancer, TLH may be an appropriate therapy given it’s equivalent disease-free survival and overall survival compared to TAH and its potential benefits in terms of post-operative recovery.

Click to read the study in JAMA

Relevant Reading: Quality of life after total laparoscopic hysterectomy versus total abdominal hysterectomy for stage I endometrial cancer (LACE): a randomized trial

RELATED REPORTS

Lenvatinib plus pembrolizumab increased survival for advanced endometrial cancer patients when compared to chemotherapy

Quick Take: Pregnancy duration and endometrial cancer risk

2 Minute Medicine Rewind August 19, 2019

In-Depth [randomized controlled trial]: This study was a multinational, phase 3, randomized equivalence trial that took place between 2005 and 2010 at 20 tertiary gynecological cancer centers in Australia, New Zealand, and Hong Kong. The authors randomized 760 women with stage I endometrial cancer to either TAH or TLH and patients were followed-up for a median of 4.5 years. Disease-free survival was 81.3% in the TAH group vs. 81.6% in the TLH group, with a difference of 0.3% (CI95% -5.5% to 6.1%, p = 0.7) that met the criteria for equivalence. Recurrence of endometrial cancer was 7.9% in the TAH group vs. 8.1% in the TLH group (risk difference 0.2%; CI95% -3.7% to 4.0%, p = 0.93) and thus there was no statistically significant difference. Similarly, there was no difference in overall survival, with 92.4% surviving at 4.5 years in the TAH group vs. 92.0% in the TLH group (HR 1.08; CI95% 0.63 to 1.85, p = 0.78).

 

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: endometrial cancerhysterectomy
Previous Post

2 Minute Medicine Rewind March 27, 2017

Next Post

Study suggests shift away from pharmacologic management of patent ductus arteriosus

RelatedReports

Recurrence of endometrial hyperplasia following medical therapy is common
Oncology

Lenvatinib plus pembrolizumab increased survival for advanced endometrial cancer patients when compared to chemotherapy

March 27, 2022
Risk of autism in offspring linked to maternal pregestational diabetes and severe obesity
Obstetrics

Quick Take: Pregnancy duration and endometrial cancer risk

September 1, 2019
2 Minute Medicine Rewind August 19, 2019
Weekly Rewinds

2 Minute Medicine Rewind August 19, 2019

August 28, 2019
Needlestick injuries most common in first six months of residency
Obstetrics

Robotic surgery faster with similar outcomes for endometrial cancer

June 12, 2016
Next Post
Digital imaging detects sight-threatening retinopathy of prematurity

Study suggests shift away from pharmacologic management of patent ductus arteriosus

Childhood asthma rates decreasing, except among the poor

Childhood lead exposure linked with lower socioeconomic status and cognition in middle age

Thrombophilia-associated stillbirth risk appears limited to factor V Leiden

Extended rivaroxaban superior to aspirin in lowering risk of recurrent venous thromboembolism: The EINSTEIN CHOICE trial

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • 2 Minute Medicine Rewind July 4, 2022
  • Stereotactic body radiotherapy as a state of the art treatment option in inoperable non-small cell lung cancer [Classics Series]
  • Health system-based care associated with better treatment use and high rates of tobacco abstinence at 3 months post-discharge in hospitalized smokers
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.